Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates.
Cairo MS, Agosti J, Ellis R, Laver JJ, Puppala B, deLemos R, Givner L, Nesin M, Wheeler JG, Seth T, van de Ven C, Fanaroff A. Cairo MS, et al. Among authors: agosti j. J Pediatr. 1999 Jan;134(1):64-70. doi: 10.1016/s0022-3476(99)70373-2. J Pediatr. 1999. PMID: 9880451 Free article. Clinical Trial.
Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.
Cairo MS, Christensen R, Sender LS, Ellis R, Rosenthal J, van de Ven C, Worcester C, Agosti JM. Cairo MS, et al. Among authors: agosti jm. Blood. 1995 Oct 1;86(7):2509-15. Blood. 1995. PMID: 7670096 Free article. Clinical Trial.
The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: a randomized double-blind, placebo-controlled trial.
Skowron G, Stein D, Drusano G, Melbourne K, Bilello J, Mikolich D, Rana K, Agosti JM, Mongillo A, Whitmore J, Gilbert MJ. Skowron G, et al. Among authors: agosti jm. J Infect Dis. 1999 Oct;180(4):1064-71. doi: 10.1086/314981. J Infect Dis. 1999. PMID: 10479132 Clinical Trial.
Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trial.
Nemunaitis J, Cox J, Meyer W, Courtney A, Hanson T, Green-Weaver C, Agosti J. Nemunaitis J, et al. Among authors: agosti j. Am J Clin Oncol. 1998 Jun;21(3):308-12. doi: 10.1097/00000421-199806000-00023. Am J Clin Oncol. 1998. PMID: 9626806 Clinical Trial.
115 results